Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

Pediatr Blood Cancer. 2016 Oct;63(10):1868. doi: 10.1002/pbc.26078. Epub 2016 Jul 9.

Authors

Jean S Lee¹, Katherine Matthay¹, Steven G DuBois², Arup Roy-Burman³

Affiliations

¹ Division of Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, California.
² Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.
³ Division of Critical Care, Department of Pediatrics, University of California, San Francisco, California.

PMID: 27394054
DOI: 10.1002/pbc.26078

No abstract available

Publication types

Letter
Kommentar

MeSH terms

3-Iodobenzylguanidine*
Child
Humans
Iodine Radioisotopes
Neuroblastoma*

Substances

Iodine Radioisotopes
3-Iodobenzylguanidine